✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
After the allogeneic transplantation we did not only observe remission of the lymphoblastic lymphoma but also the disappearance of b thalassemia minor.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:$\beta$ thalassemia minor is frequent in mediterranean countries.
📊
Key Findings & Data:We transplanted a 25-year-old Turkish male who was diagnosed as lymphoblastic lymphoma and had $\beta$ thalassemia minor as well.
💡
Conclusion & Impact:After the allogeneic transplantation we did not only observe remission of the lymphoblastic lymphoma but also the disappearance of b thalassemia minor.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Nakil · homolog · Erişkin
Özet
$\beta$ thalassemia minor is frequent in mediterranean countries. İt is a benign disorder and does not warrant any therapeutical intervention. We transplanted a 25-year-old Turkish male who was diagnosed as lymphoblastic lymphoma and had $\beta$ thalassemia minor as well. He received peripheral blood stem cells transplantation from his HLA-identical sibling who was not a carrier of $\beta$ thalassemia. After the allogeneic transplantation we did not only observe remission of the lymphoblastic lymphoma but also the disappearance of b thalassemia minor.
🔖
Cite This Article
ÇELEBİ, H., ÜSTÜN, C., ARAT, M., AKAN, H., TUNÇMAN, G., ÖZÇELİK, T., COŞKUN, H. Ş., KOÇ, H. (2000). An extra benefit of allogeneic peripheral blood stem cell transplantation in a patient with lymphoblastic lymphoma: Cure of thalassemia minor. Turkish Journal of Hematology, Cilt: 17 - Sayı: 2, 77–79. https://ajindex.com/articles/413445